Teva Pharmaceutical Industries Ltd. ADR 1.42% $19.56B ...

XDefiant's last seasonal content drop is here as update 1.000.032, and the devs have piled on everything they have with a ton ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

South African sim racing extraordinaire, David Perel, clarifies its meteoric rise and what influence it'll have on future ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

But, increased costs became a drag on net income in 2023 as firms invested in technology and infrastructure. Further ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 38,541.57 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

Read on to learn more about XDefiant Season 3 patch notes. Looking for Crossword hints & solutions? Check out latest NYT Mini Crossword Answers, LA Times Crossword Answers, and USA Today Crossword ...

The final major XDefiant content drop is here, so check out the full patch notes for the huge Season 3 update.